In The News

Thermedical scores FDA breakthrough designation for ablation system to treat ventricular tachycardia

May 19, 2020

Thermedical SERF Ablation System  Earns FDA Breakthrough Devise Designation

May 19, 2020

CRN%20Log_edited.jpg
Durablate catheter results demonstrate feasibility in VT ablation
First published in Cardiac Rhythm News on May 15, 2020

May 15, 2020

May 8, 2013

May 15, 2013

The Thermedical® Ablation System is 510(k) cleared for the coagulation and ablation of soft tissue during percutaneous, laparoscopic and intraoperative surgical procedures.  Use of the Thermedical Ablation System for any specific soft tissue indication has not been evaluated or approved by the US FDA.

Use of the Thermedical Ablation System for the treatment of VT is investigational and is not approved for use or sale in any market.

150 Bear Hill Road,  Waltham, MA 02451-1036
781.373.3688

©Copyright Thermedical, Inc. 2011-2015. All Rights Reserved. | Copyright and Trademark Notice 
Thermedical® and Durablate™ are trademarks of Thermedical, Inc. registered in the United States and Internationally.